4//SEC Filing
SENYEI ANDREW E 4
Accession 0001181431-11-060888
CIK 0001361103other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:05 PM ET
Size
11.8 KB
Accession
0001181431-11-060888
Insider Transaction Report
Form 4
SENYEI ANDREW E
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock, par value $0.001
2011-11-30+1,666→ 1,666 total - Purchase
Common Stock, par value $0.001
2011-12-14$3.05/sh+100,000$305,000→ 201,043 total(indirect: See Footnote) - Exercise/Conversion
Restricted Stock Units
2011-11-30−1,666→ 3,334 total→ Common Stock (1,666 underlying)
Holdings
- 2,052,418(indirect: See Footnote)
Common Stock, par value $0.001
- 667,068(indirect: See Footnote)
Common Stock, par value $0.001
Footnotes (6)
- [F1]The shares were acquired upon vesting and conversion of Restricted Stock Units, which were received as a grant for which no consideration was paid.
- [F2]The shares are owned by Enterprise Partners Management, LLC ("Enterprise LLC"). Andrew E. Senyei, M.D. is a managing director of Enterprise LLC and shares voting and investment power over the shares held by Enterprise LLC. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- [F3]The shares are owned by Enterprise Partners VI, LP (Enterprise VI"). Enterprise Management Partners VI, LLC (Enterprise VI LLC") serves as the general partner of Enterprise VI. Andrew E. Senyei, M.D. is a managing director of Enterprise VI LLC and shares voting and investment power over the shares held by Enterprise VI. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- [F4]The shares are owned by Enterprise Partners V, LP ("Enterprise V"). Enterprise Management Partners V, LLC ("Enterprise V LLC") serves as the general partner of Enterprise V. Andrew E. Senyei, M.D. is a managing director of Enterprise V LLC and shares voting and investment power over the shares held by Enterprise V. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- [F5]Upon vesting, Reporting Person is entitled to receive one share of common stock for each restricted stock unit.
- [F6]The restricted stock units vest in three successive and equal annual installments measured from November 30, 2010, such that the restricted stock units will vest in full on the third anniversary of November 30, 3010, subject to the Reporting Person's continued employment or service relationship with the Issuer on each of the vesting dates. Such restricted stock units include a change of control provision such that all unvested awards will immediately vest and become exercisable in connection with a change of control of Issuer.
Documents
Issuer
COMPLETE GENOMICS INC
CIK 0001361103
Entity typeother
Related Parties
1- filerCIK 0001250018
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:05 PM ET
- Size
- 11.8 KB